Literature DB >> 21125363

Divergent squamous differentiation in upper urothelial carcinoma-comparative clinicopathological and molecular study.

Ljubinka Jankovic Velickovic1, Zana Dolicanin, Takanori Hattori, Ivana Pesic, Biljana Djordjevic, Mariola Stojanovic, Jablan Stankovic, Milan Visnic, Vladisav Stefanovic.   

Abstract

Upper urothelial carcinoma (UUC) has a plasticity to demonstrate divergent differentiation with squamous metaplastic elements. There was no previous study exploring profiling of molecular markers in metaplastic squamous upper urothelial carcinoma (SUUC) and conventional upper urothelial carcinoma (CUUC). The aims of this study was to compare expression of the phenotypic characteristics of tumors and molecular markers (p53, p16, cyclin D1, E-cadherin, HER-2, Ki-67, Bcl-2, Bax) in SUUC and CUUC. SUUC was detected in 20% of 44 patients. There was significant difference between SUUC and CUUC in the pathological stage, grade, growth and presence of lymphovasular invasion (p < 0.05; 0.05; 0.05; 0.01 respectively). The mean Ki-67 and p53 labeling index was significantly higher in SUUC than in CUUC (p < 0.05; 0.05). There was no significant difference in the expression of p16, cyclin D1, E-cadherin, HER-2, Bcl-2 and Bax between SUUC and CUUC. Univariant model showed that SUUC was significantly associated with lymphovascular invasion (p = 0.007), Ki-67 activity (p = 0.016) and growth (p = 0.026). Exploration of UUC with squamous divergent differentiation showed changes in phenotypic characteristics and Ki-67, as well as similar molecular profile with CUUC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21125363     DOI: 10.1007/s12253-010-9343-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.

Authors:  Antonio Lopez-Beltran; Maria J Requena; Jose Alvarez-Kindelan; Ana Quintero; Ana Blanca; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

2.  Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Authors:  Gaëlle Fromont; Morgan Rouprêt; Najla Amira; Mathilde Sibony; Guy Vallancien; Pierre Validire; Olivier Cussenot
Journal:  Eur Urol       Date:  2005-08-01       Impact factor: 20.096

3.  Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer.

Authors:  W F Benedict; S P Lerner; J Zhou; X Shen; H Tokunaga; B Czerniak
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

4.  Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.

Authors:  M-T Sung; M Wang; G T MacLennan; J N Eble; P-H Tan; A Lopez-Beltran; R Montironi; J J Harris; M Kuhar; L Cheng
Journal:  J Pathol       Date:  2007-03       Impact factor: 7.996

Review 5.  Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.

Authors:  J H Shanks; K A Iczkowski
Journal:  Histopathology       Date:  2008-10-30       Impact factor: 5.087

Review 6.  Molecular and histological markers in urothelial carcinomas of the upper urinary tract.

Authors:  Stephanie Eltz; Eva Comperat; Olivier Cussenot; Morgan Rouprêt
Journal:  BJU Int       Date:  2008-04-02       Impact factor: 5.588

Review 7.  Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review.

Authors:  Elizabeth M Genega; Christopher R Porter
Journal:  Am J Clin Pathol       Date:  2002-06       Impact factor: 2.493

8.  Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney.

Authors:  Elizabeth M Genega; Malathy Kapali; Marta Torres-Quinones; William C Huang; Jill S Knauss; Li-Ping Wang; Puthiyaveettil N Raghunath; Christopher Kozlowski; Stanley Bruce Malkowicz; John E Tomaszewski
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

Review 9.  The impact of variant histology on the outcome of bladder cancer treated with curative intent.

Authors:  Peter C Black; Gordon A Brown; Colin P N Dinney
Journal:  Urol Oncol       Date:  2008-01-14       Impact factor: 3.498

10.  High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.

Authors:  Delia Perez-Montiel; Paul E Wakely; Ondrej Hes; Michal Michal; Saul Suster
Journal:  Mod Pathol       Date:  2006-04       Impact factor: 7.842

View more
  1 in total

1.  Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy.

Authors:  Gang Li; Jieping Hu; Yuanjie Niu
Journal:  Oncotarget       Date:  2017-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.